• Wondering whether Privia Health Group at around US$23.99 is offering fair value or a potential opportunity? This article breaks down what the current price may be telling you.
• The stock has been volatile recently, with a 3.5% decline over the last 7 days, a 7.2% gain over the last 30 days, and year to date returns of 2.3% after a 4.3% loss over the past year.
• Those mixed returns come against a backdrop of ongoing interest in healthcare services companies focused on physician enablement and practice efficiency. This often brings Privia Health Group into investor conversations when healthcare reform and care delivery models are in the news. Broader sector themes, such as consolidation in provider groups and shifts in insurer relationships, can also affect sentiment around stocks like Privia Health Group even without company specific headlines.
• Simply Wall St currently gives Privia Health Group a valuation score of 3 out of 6. The rest of this article will compare different valuation approaches before circling back to a more complete way to think about what that score might mean for you.

Approach 1: Privia Health Group Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model takes the cash flows a company is expected to generate in the future and discounts them back to today using a required rate of return, aiming to estimate what those future dollars are worth right now.

For Privia Health Group, the model used is a 2 Stage Free Cash Flow to Equity approach. The company’s latest twelve month free cash flow is reported at $138 million. Analysts provide explicit forecasts for several years, and Simply Wall St then extrapolates further out, with projected free cash flow of $204 million in 2030. Additional ten year projections for free cash flow, all in $, are used to build a full stream of expected cash flows that are then discounted.

On this basis, the DCF model arrives at an estimated intrinsic value of $42.51 per share. Compared with the recent share price of about $23.99, this implies the stock is 43.6% undervalued according to these assumptions and inputs.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Privia Health Group is undervalued by 43.6%. Track this in your watchlist or portfolio, or discover 51 more high quality undervalued stocks.

Approach 2: Privia Health Group Price vs Earnings

For profitable companies, the P/E ratio is a straightforward way to check how much investors are paying for each dollar of earnings. It links the share price directly to current earnings, which is often the first anchor investors look at when deciding if a stock feels expensive or reasonable.

What counts as a “fair” P/E depends heavily on growth expectations and risk. Higher expected earnings growth or lower perceived risk can support a higher P/E, while slower growth or higher risk typically lines up with a lower multiple.

Privia Health Group currently trades on a P/E of 138.48x. That sits well above the Healthcare industry average of 22.13x and the peer group average of 26.25x. Simply Wall St’s Fair Ratio for Privia Health Group is 28.99x, which is a proprietary estimate of what the P/E might be given factors like earnings growth, profit margins, industry, market cap and risk profile.

The Fair Ratio is more tailored than a simple comparison with peers or the industry, because it adjusts for company specific traits instead of assuming all healthcare stocks deserve the same multiple. With the current P/E far above the Fair Ratio, this approach points to the stock trading at a richer valuation than those fundamentals would suggest.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 18 top founder-led companies.

Upgrade Your Decision Making: Choose your Privia Health Group Narrative

Earlier the article mentioned that there is an even better way to understand valuation, and on Simply Wall St this is done through Narratives. Narratives let you attach a clear story about Privia Health Group to your own assumptions for future revenue, earnings and margins, link that story to a forecast and fair value, and then compare that fair value with the current price to help frame buy or sell decisions. Narratives on the Community page are built and updated by investors using the same platform that millions of others already use, and they refresh automatically when new information appears, such as earnings, guidance or news. For Privia Health Group, one investor might build a Narrative that leans into fee for service timing, value based care growth and technology investments and conclude the stock is worth closer to the higher analyst target of US$40. Another might focus on consolidation risks, labor costs and contract pressure and land nearer the lower target of US$25. These two Narratives can sit side by side so you can see exactly which assumptions lead to each view.

Do you think there's more to the story for Privia Health Group? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.